A study of a new medicine (fazpilodemab) in people with a type of liver disease called non-alcoholic steatohepatitis or NASH

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of BFKB8488A Compared With Placebo in Participants With Non-Alcoholic Steatohepatitis

Metabolic Disorder
Non Alcoholic Steato-Hepatitis
Kidney Disorder
Chronic Kidney Disease

Results
Download
Print

Study results

LPS GC41033 Final Results February 2024 English (PDF, 0.2 MB)

LPS GC41033 Final Results February 2024 French (PDF, 0.2 MB)

LPS GC41033 Final Results February 2024 Spanish (PDF, 0.2 MB)

What is Clinical Research?

In clinical research, volunteers, researchers, and medical professionals work together toward a shared goal: better treatment outcomes for patients. Clinical trials are vital to their process. They are carefully designed and follow approved protocols.

A study of a new medicine (fazpilodemab) in people with a type of liver disease called non-alcoholic steatohepatitis or NASH

Study results

LPS GC41033 Final Results February 2024 English (PDF, 0.2 MB)

LPS GC41033 Final Results February 2024 French (PDF, 0.2 MB)

LPS GC41033 Final Results February 2024 Spanish (PDF, 0.2 MB)

What is Clinical Research?

For the latest version of this information please go to www.forpatients.roche.com

Directly contact Roche for questions

Contact the hospital directly

Thank you

Something went wrong

Request a call back

Find participating medical centers and current study status in each of them

A study of a new medicine (fazpilodemab) in people with a type of liver disease called non-alcoholic steatohepatitis or NASH

For the latest version of this information please go to www.forpatients.roche.com